日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growth.

靶向巨噬细胞的CAR-T细胞能够重置和重编程肿瘤微环境,并控制转移性癌症的生长。

Mateus-Tique Jaime, Lakshmi Ashwitha, Singh Bhavya, Iyer Rhea, Sánchez-Paulete Alfonso R, Falcomatà Chiara, Lin Matthew, Pantsulaia Gvantsa, Tepper Alexander, Nguyen Trung, Amabile Angelo, Mollaoglu Gurkan, Pia Luisanna, Chhamalwan Divya, Le Berichel Jessica, Potak Hunter, Colonna Marco, Baccarini Alessia, Brody Joshua, Merad Miriam, Brown Brian D

Potentiating CAR-T bystander killing by enhanced Fas/FasL signaling mitigates antigen escape in heterogeneous tumors

通过增强 Fas/FasL 信号传导来增强 CAR-T 细胞的旁观者杀伤作用,可以减轻异质性肿瘤中的抗原逃逸现象。

Lin, Matthew J; Chorazeczewski, Joanna K; Pantsulaia, Gvantsa; Cooper, Alan; Sohn, Moah; Reci, Sidorela; Mateus-Tique, Jaime; Hirsh, Nicole H; Xie, Xinping; Odak, Ivan; Dutta, Rudra; Charytonowicz, Daniel; Upadhyay, Ranjan; Brown, Brian D; Merad, Miriam; Huse, Morgan; Kline, Justin; Brody, Joshua D

Pattern recognition receptor agonists in pathogen vaccines mediate antitumor T-cell cross-priming

病原体疫苗中的模式识别受体激动剂介导抗肿瘤T细胞交叉启动

Aleynick, Mark; Svensson-Arvelund, Judit; Pantsulaia, Gvantsa; Kim, Kristy; Rose, Samuel A; Upadhyay, Ranjan; Yellin, Michael; Marsh, Henry; Oreper, Daniel; Jhunjhunwala, Suchit; Moussion, Christine Carine; Merad, Miriam; Brown, Brian D; Brody, Joshua D

Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity.

扩增交叉呈递树突状细胞可增强溶瘤病毒疗法,对长期抗肿瘤免疫至关重要

Svensson-Arvelund Judit, Cuadrado-Castano Sara, Pantsulaia Gvantsa, Kim Kristy, Aleynick Mark, Hammerich Linda, Upadhyay Ranjan, Yellin Michael, Marsh Henry, Oreper Daniel, Jhunjhunwala Suchit, Moussion Christine, Merad Miriam, Brown Brian D, García-Sastre Adolfo, Brody Joshua D